期刊文献+

Acceleration of coasting enhances pregnancy rate in ICSI cycles at risk for ovarian hyperstimulation syndrome

Acceleration of coasting enhances pregnancy rate in ICSI cycles at risk for ovarian hyperstimulation syndrome
原文传递
导出
摘要 Objective To assess the efficacy of adding Gn-releasing hormone antagonist(GnR HA) on the day of hC G triggering in a long luteal protocol without withholding the agonist in women who are at a risk to develop ovarian hyperstimulation syndrome(OHSS).Methods This was a retrospective cohort study conducted upon 50 women who have elevated serum estradiol(E2) level 〉4 500 ng/L at the day of ovum triggering with hC G on a long agonist luteal protocol of controlled ovarian stimulation(COS). When an exaggerated ovarian response was observed around day 10 of stimulation, immediately the next morning at 6 a.m. gonadotropin administration was stopped or reduced, and a single dose of ganirelix acetate(antagonist) was given sc continuation of the agonist dose hC G. Another serum E2 measurement was done at 6 p.m.(after 12 h of antagonist) then hC G, sc 250 mg and choriogonadotropin α were administered 14 h later after antagonist and documented the reduction of E2 level. Oocyte retrieval was conducted after 34-36 h of hC G administration. The measured outcomes were the level of E2 on the day of hC G injection, number of oocytes and their quality, pregnancy rate and the occurrence of OHSS and its grade in case it happened.Results The total dose for recombinant FSH was 25.3±6.4 ampoules(75 IU/ampoule) while it was 11.0±3.0 ampoules for the urinary hM G. A higher oocyte maturation rate(82.8%) and a high fertilization rate(87.8%) were observed. The mean endometrial thickness was 10.1±1.0 mm on the day of hC G triggering. The higher fertilization rate with the good endometrial thickness observed resulting in a higher pregnancy rate(78.0%, 39/50) with statistically significant(P〈0.05). A significant reduction of E2 level was documented by a percentage around 40% before hC Ginjection. There were no reported cases of severe or moderate OHSS, however 13 cases(26%) were reported to have mild OHSS constituting.Conclusion Acceleration of coasting in cases of OHSS through treatment with GnR HA after pituitary suppression with GnR H agonist(GnR H-a) offered a novel approach to decrease E2 level, avoided cycle cancellation, and maintain excellent oocyte maturation rate, and finally result in high pregnancy rate with prevention of OHSS. Objective To assess the efficacy of adding Gn-releasing hormone antagonist(GnR HA) on the day of hC G triggering in a long luteal protocol without withholding the agonist in women who are at a risk to develop ovarian hyperstimulation syndrome(OHSS).Methods This was a retrospective cohort study conducted upon 50 women who have elevated serum estradiol(E2) level 〉4 500 ng/L at the day of ovum triggering with hC G on a long agonist luteal protocol of controlled ovarian stimulation(COS). When an exaggerated ovarian response was observed around day 10 of stimulation, immediately the next morning at 6 a.m. gonadotropin administration was stopped or reduced, and a single dose of ganirelix acetate(antagonist) was given sc continuation of the agonist dose hC G. Another serum E2 measurement was done at 6 p.m.(after 12 h of antagonist) then hC G, sc 250 mg and choriogonadotropin α were administered 14 h later after antagonist and documented the reduction of E2 level. Oocyte retrieval was conducted after 34-36 h of hC G administration. The measured outcomes were the level of E2 on the day of hC G injection, number of oocytes and their quality, pregnancy rate and the occurrence of OHSS and its grade in case it happened.Results The total dose for recombinant FSH was 25.3±6.4 ampoules(75 IU/ampoule) while it was 11.0±3.0 ampoules for the urinary hM G. A higher oocyte maturation rate(82.8%) and a high fertilization rate(87.8%) were observed. The mean endometrial thickness was 10.1±1.0 mm on the day of hC G triggering. The higher fertilization rate with the good endometrial thickness observed resulting in a higher pregnancy rate(78.0%, 39/50) with statistically significant(P〈0.05). A significant reduction of E2 level was documented by a percentage around 40% before hC Ginjection. There were no reported cases of severe or moderate OHSS, however 13 cases(26%) were reported to have mild OHSS constituting.Conclusion Acceleration of coasting in cases of OHSS through treatment with GnR HA after pituitary suppression with GnR H agonist(GnR H-a) offered a novel approach to decrease E2 level, avoided cycle cancellation, and maintain excellent oocyte maturation rate, and finally result in high pregnancy rate with prevention of OHSS.
出处 《Journal of Reproduction and Contraception》 CSCD 2016年第2期103-111,共9页 生殖与避孕(英文版)
关键词 ovarian hyperstimulation syndrome(OHSS) COASTING oocyte maturation pregnancy rate ovarian hyperstimulation syndrome(OHSS) coasting oocyte maturation pregnancy rate
  • 引文网络
  • 相关文献

参考文献31

  • 1Naredi N, Talwar P, Sandeep K. VEGF antagonist for the prevention of ovarian hyperstimulation syndrome:Current status. Med J Armed Forces India, 2014, 70(1):58-63.
  • 2MacDougall MJ, Tan SL, Jacobs HS. In vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod, 1992, 7(5):579-600.
  • 3Wada I, Matson PL, Troup SA, et al. Ovarian hyperstimulation syndrome in GnRH-a/hMG cycles for IVF and GIFT. J Obstet Gynaecol, 1990, 11(4):88-9.
  • 4Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril, 1992, 58(2):249-61.
  • 5A1-ShawafT, Zosmer A, Hussain S, et al. Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified "coasting" strategy based on ultrasound identification of high-risk patients. Hum Reprod, 2001, 1(16):24-30.
  • 6D'Angelo A, Brown J, Amso NN. Coasting (withholding gonadotrophins) for preventing ovarian hyper- stimulation syndrome. Cochrane Database Syst Rev, 2010, 15(6):CD002811.
  • 7Sher G, Salem R, FeinmanM, et al. Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer. Obstet Gynaecol, 1993, 81(6):1009-11.
  • 8Sher G, Zouves C, FeinmanM, et al. "Prolonged coasting": an effective method for preventing severe ovarian hyperstimulation syndrome in patients tmdergoing in-vitro fertilization. Hum Reprod, 1995, 10(12) :3107 -9.
  • 9Isaza V, GarciaVelasco JA, Aragones M, et al. Oocyte and embryo quality after coasting: the experience from oocyte donation. Hum Reprod, 2002, 17(7): 1777-82.
  • 10Mansour R, Aboulghar M, Serour G, et al. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome. Hum Reprod, 2005, 20(11):3167-72.
;
使用帮助 返回顶部